Company Held 2016 Board of Directors and Board of Supervisors

to Review and Pass the Board's Work Report and Other Proposals and Reports

News 4# November 15 , the 11 Meeting of the 9th Board of Directors of the Group Company was held in Jianfeng Building, deliberated and passed 2016 Board of Directors Work Report, 2016 General Manager Work Report and other 14 proposals and reports. The

meeting was presided over by Jiang Xiaomeng, chairman of the group company. Yu Jianhong, general manager, made an annual work report on behalf of the management team, comprehensively summarizing and reviewing the company's 2016 work.

In 2016 , the company focused on the general policy of "innovation, integration, improvement, and development", actively sought new opportunities for development, made new breakthroughs in cooperative innovation, carried out in-depth management integration, continuously improved management levels, and strengthened marketing Management and market expansion have achieved steady growth in product sales, technological innovation and technological transformation have achieved obvious results, and corporate image and influence have been effectively improved. The company realized operating income of 23.79 .2 billion yuan for the whole year, up 5.34% year on year. Net profit attributable to owners of the parent company 28522.95 yuan, up 41.98% year on year, the highest level in history. By the end of 2016 , the company's total assets were 39.95 .2 billion yuan, up 10% year on year. Net assets were 25.52 .6 billion yuan, up 9.82 year on year.

2016 , thanks to the national strategy of "the belt and road initiative", the national cement production increased by 2.3% year-on-year, driven by the recovery of infrastructure investment and real estate investment. The growth of total demand, the development and construction of the southwest region and the implementation of a series of structural reform measures on the supply side of the cement industry, including peak production, industry self-discipline and market integration, cement prices rebounded after bottoming out in the first half of 2016 , and the cement industry in some areas improved. The company's cement business sector seized the opportunity of supply-side reform, actively advocated industry self-discipline, and worked closely around the cost-leading strategy. Daye Peak actively participated in large-scale project bidding while increasing the expansion of the civil market for bagged cement, striving to maintain the gross profit level of tons of cement and ensuring the balance of production and sales in the off-season market. Yunnan Peak strives to enhance the brand status of Peak Cement and advocates self-discipline in the cement industry in southwest Yunnan, actively develop key projects, continue to expand market share, and significantly improve economic efficiency.

Peak Pharmaceutical strives to seek new projects and make new breakthroughs according to strategic planning. In terms of business development, Jianfeng Pharmaceutical has introduced advanced German technology and established a Sino-German joint venture Zhejiang Jindal Baby Drug Co., Ltd. to build a platform specializing in the research and development, production and operation of infant drugs. After more than half a year of research and negotiation, it successfully reached an agreement with Beihui Biology's major shareholders to take a stake in Beihui Biology by way of capital increase and equity transfer. In terms of equity investment, the company also completed the capital increase of Peak Pharmaceuticals and Tianshili Group. In terms of product sales, efforts have been made to realize the entry of peak pharmaceutical products into various catalogues. Jinhua Pharmaceutical Company has obtained the qualification of main distribution in Yiwu primary hospitals. Peak pharmacy has added 4 chain stores and 4 designated medical insurance pharmacies, realizing sales growth. In terms of technological innovation, the research and development project of Jianfeng Pharmaceutical's new anti-tumor drug DPT (deoxypodophyllotoxin) is progressing smoothly, and it has obtained clinical trial approval documents issued by CFDA and obtained a number of related invention patents.

peak health food extraction workshop passed GMP certification, extraction workshop passed Kosher (clean food), halal (halal) certification, and passed ISO9001 , ISO22000 system on-site audit; Complete the drug production record of Ginkgo biloba extract and the establishment of GMP management system, complete the certification of SC for 5 unit foods such as jelly, flavored tea, plant beverages, etc. Tianjin Jianfeng Natural Products Company has strengthened the development of the domestic market while continuing to expand the international market, realizing the simultaneous growth of international and domestic market sales. Peak cable through the product system, Ter and other certification supervision and inspection, large logarithmic cable successfully entered the Hangzhou G20 project. At the same time, the company takes budget management and benchmarking management as the guidance, fine management and PDCA

cycle management as the method, comprehensively carries out the "three reductions and three improvements" activities with the core of reducing costs, reducing expenses and reducing employment, improving work efficiency, improving marketing ability and improving innovation ability, continuously promoting management improvement and providing guarantee for the further development of the company. The board of directors of

also deliberated and approved the "plan on profit distribution for 2016

" and decided to distribute cash for

2016 , based on 2016 year-end share capital ,344,083, 828 shares, and distribute cash dividend 2.5 yuan (including tax) for every 10 shares, the total amount of cash dividends distributed to all shareholders registered on the date of record is 86,020,957.00 yuan (including tax), and 2016 will not be converted into share capital. The distribution plan still needs to be approved by the general meeting of shareholders. If it is implemented, the cash dividend accumulated by the company to shareholders in the last three years will reach 23397.70 .14 million yuan. On the same day, 115 , the company also held the 119 meeting of the 10th 118 of the 8th board of supervisors, deliberated and passed the 123 proposals and reports of the 5th board of supervisors of the company 2016 and the proposal on adding supervisors. (Zhou Hengbin)